Pharma Market Access Insights - from Petauri Evidence – Details, episodes & analysis

Send us a text

Discover how data visualisation dashboards can aid field teams in market access discussions with customers.

Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted partner. Watch this 20-minute discussion between Iain Shield (Associate Director – Market Access) and Ben Spurr (Head of Partnerships) to discover how Connected Insights data visualisation dashboards can help your teams have strategic conversations with healthcare decision-makers. Iain also explains typical use cases for the dashboards for field teams, why data dashboards are useful for the NHS, and what sets Connected Insights dashboards apart.

Learn more about this showcase at: https://mtechaccess.co.uk/engage-nhs-with-rwd/

Learn more about real-world data visualisation at: https://mtechaccess.co.uk/digital-capabilities/real-world-data-market-access/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health (CADTH) in 2024/2025?  In this webinar, Clare Foy (Director – Global Market Access, Mtech Access) interviewed Don Husereau (Adjunct Professor of Medicine, The University of Ottawa).

We take a look at the market access, health policy, and health technology assessment in Canada. Clare Foy and Don Husereau explore:

• The market access landscape in Canada
• Upcoming changes at CADTH
• What Canadian payers expect from your value proposition
• Opportunities and challenges when launching new medicines/medical devices/diagnostics in Canada
• How Canada compares to the USA/key European launch markets
• What this means for your global market access strategy

This episode was first broadcast as a live webinar in March 2024. Learn more at https://mtechaccess.co.uk/market-access-canada-changes-cadth/


Learn more about the Canadian healthcare market and launching new pharma and medtech innovations at: https://mtechaccess.co.uk/launching-healthcare-products-in-canada/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

Clare Foy (Director – Global Market Access, Mtech Access) speaks to Italian market access expert Prof. Fabrizio Gianfrate (Professor of Health Economics and Outcomes Research [HEOR] and Ex-Payer) about the market access landscape in Italy, particularly regarding changes at the Agenzia Italiana del Farmaco (AIFA).

We explore:
- The nature of the Italian market and the reimbursement process
- Pricing and market access considerations when launching in Italy
- What the reforms at AIFA mean for market access and managed entry agreements
- How the AIFA changes specifically impact innovative products
- Changes to early access programmes in Italy
- Impact of these changes on international pricing, particularly with the introduction of the EU Joint Clinical Assessment (JCA)

This episode was first broadcast as a live webinar in October 2023. Learn more at: https://mtechaccess.co.uk/italy-market-access-aifa-reforms/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

Dr Farzana Hussain (GP Principal, The Project Surgery) and Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) explore the unmet needs of Primary Care Networks (PCNs) and how industry can best support primary care leaders and GPs as we head into winter, 2024 and beyond.

Former ‘GP of the year’ and strategic influencer over primary care policy, Dr Farzana Hussain, discusses the unmet needs in primary care, how primary care leaders are responding to these challenges, and where industry can best offer support.

Phil and Farzana discuss:

•  How unmet needs are identified in primary care, the processes followed, and datasets used to inform decision making
•  The specific challenges facing primary care as we head into winter
•  The role of PCN leaders and their impact on national policy
•  How industry can best support and collaborate with PCNs
•  Ongoing lessons from the pandemic and the vaccine roll-out

Learn more about this webinar at: https://mtechaccess.co.uk/unmet-need-nhs-primary-care/

Discover or NHS Insight and UK market access services: https://mtechaccess.co.uk/uk-nhs-insights/

This episode was first broadcast as a live webinar in October 2023. 

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How can our community support NHS leaders to deliver a data-led, people-centric health service?

Dr Mark Davies (Global Chief Health Officer, IBM) joins Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) to explore the power of data, the role of community and how the health and life sciences ecosystem can support the NHS’s population health management goals.

Population health management has the potential to be a powerful tool for healthcare systems, effecting the way health and care is strategised, budgeted, targeted, and delivered. We see a future where key decisions in the NHS are driven by population health data. What we now need is a new way of working powered by local need, quality evidence and a systematic approach.

In this webinar, Phil and Mark explore:

 - How the NHS can use population health management to transform the system
 - The importance of community in population health management
 - How Pharma, Medtech, and the wider life sciences sector can work above brand to support the NHS with population health management
 - What a data-driven, people-centric approach means for the way treatments are valued
 - How population health management could transform the economics of healthcare

This episode was first broadcast as a live webinar on Friday 8th September 2023. Learn more at: https://mtechaccess.co.uk/uk-nhs-insights/

Discover more about our work in this area at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How is Artificial Intelligence being used in the development of new medicines? What role can AI currently play in clinical trials? Where can AI bridge gaps and solve challenges? What could this mean for the future of market access?

In this webinar, Dr George Magrath explains how his team at Lexitas are using AI in clinical trials in the field of ophthalmology. George and Calum explore:

- How, when and where AI is being used in clinical trials
- How Lexitas are using AI in clinical trials for ophthalmology
- Where AI may offer solutions to existing obstacles in clinical trials and ophthalmic drug development
- What the future holds for AI in the development of new medicines
- The role AI can play in selecting patients for clinical trials
- The impact AI may have on the way we evaluate drug effectiveness
- What this all means for evidence synthesis, health economics, reimbursement and market access
- The future prospects of AI in pharmaceutical development

Learn more at: https://mtechaccess.co.uk/ai-clinical-trials-evidence/

This episode was first broadcast as a live webinar in August 2023. 

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How is the UK political landscape evolving and what does this mean for Health Technology and Medical Device innovators?

Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) speaks to William Lee (Head of Policy and Compliance, British Healthcare Trades Association [BHTA]) about health policy, regulation and its implications for Medtech, Health technologies, and Medical Device market access.

With the challenges of the pandemic and the changes brought in following Brexit, policy and compliance in the UK has been on shifting sands for several years now. With many predicting a change in government at the next election, this continues to be a time of uncertainty. What does this political landscape mean for health policy, the regulatory regime and market access?

In this on-demand webinar, Rob asks Bill about 6 areas where Medtech should be paying attention:

• MHRA and new medical device regulatory regime
• UK health and social care supply and procurement
• Sustainability and social value
• Addressing capacity challenges with effective health and social care packages
• Innovation
• Export and import – the implications of Brexit

This episode was first broadcast as a live webinar in July 2023.  Learn more about this webinar at:  https://mtechaccess.co.uk/uk-health-policy-medtech-bhta-webinar/

Learn more about our services for Medtech companies at: https://mtechaccess.co.uk/medical-device-market-access/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

Here we explore market access challenges in Germany, Austria and Switzerland. Clare Foy (Global Market Access Director – Mtech Access) speaks to Dr Stefan Walzer (CEO, President & Founder at MArS Market Access & Pricing Strategy GmbH) about the challenges and opportunities for reimbursement in the German-speaking markets.

Clare and Stefan discuss:
 - Preparing for access to Switzerland – a European market outside the EU
 - Pricing strategy and HTA decision-making in Austria under the new Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA)
 - Launching in Germany – is this still one of the most attractive European markets?
 - The Financial Stabilisation Act in Germany – what this means for drug pricing

Learn more at: https://mtechaccess.co.uk/market-acce...

This episode was first broadcast as a live webinar in July 2023. 

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

How are nursing professionals supporting the digital evolution in UK healthcare? How can new technologies be leveraged by front-line clinical teams to support improved patient care? And how can Medtech, Digital and Biotech innovators collaborate with the front-line nursing teams in the NHS to drive transformation?

Prof. Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) speaks to Jennie Smith, registered nurse, Medtech launch specialist and our new Director of NHS Insight & Interaction at Mtech Access.

Phil and Jennie explore:

 - The transformative power of technology in the NHS; particularly on patient pathways
 - The role of nurses in digital transformation and the adoption and implementation of new technologies
 - Key nursing champions, including Chief Nurse Information Officers (CNIOs)
 - How industry can best support the NHS with digital transformation
 - Our plans to bring together NHS and industry for greater collaboration

This episode was originally broadcast as a live webinar in June 2023. Learn more at: https://mtechaccess.co.uk/nursing-driving-digital-change-nhs/

Learn more about our NHS Insight & Interaction services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Send us a text

In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcomes.

In the webinar, Clare asks Shefali about:

• The opportunities for digital technologies in neurology and how they may impact existing care pathways in the future
• How the digital technology market differs from the pharmaceutical market
• Regulatory and reimbursement challenges for digital technologies
• Her experiences in launching digital technologies in markets such as the US and Germany
• How digital technologies can be used to enhance and complement existing treatments/pathways of care
• Lessons other digital health, medical device and pharmaceutical companies can learn from Shefali’s experiences

The episode was first broadcast as a live webinar in June 2023.  Learn more about this webinar at https://mtechaccess.co.uk/market-access-for-digital-therapies/

Learn how Mtech Access can support you with your market access journey at: https://mtechaccess.co.uk/global-market-access-and-pricing/ 

Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence